FF:10616-108G4: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity=J | |sample_ethnicity=J | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;8.32485843778571e-231!GO:0043226;organelle;5.2238358348898e-186!GO:0043229;intracellular organelle;3.21842386226566e-185!GO:0043231;intracellular membrane-bound organelle;5.41132955964784e-175!GO:0043227;membrane-bound organelle;5.41132955964784e-175!GO:0005737;cytoplasm;1.12899297869212e-172!GO:0044422;organelle part;1.96027698419312e-131!GO:0044446;intracellular organelle part;6.30435296380163e-130!GO:0044444;cytoplasmic part;1.99046513085584e-112!GO:0032991;macromolecular complex;1.10764520646194e-97!GO:0030529;ribonucleoprotein complex;5.13525333275091e-87!GO:0044238;primary metabolic process;1.46968027776534e-83!GO:0044237;cellular metabolic process;1.91823357352908e-82!GO:0043170;macromolecule metabolic process;1.14769999725145e-81!GO:0005634;nucleus;5.4545028540675e-76!GO:0005515;protein binding;3.21148170582664e-73!GO:0003723;RNA binding;7.93442925899601e-73!GO:0043233;organelle lumen;1.56513821386489e-71!GO:0031974;membrane-enclosed lumen;1.56513821386489e-71!GO:0044428;nuclear part;1.99359709712047e-71!GO:0005739;mitochondrion;1.44214206804257e-57!GO:0019538;protein metabolic process;8.09425869363414e-57!GO:0006412;translation;1.43057689518997e-55!GO:0006396;RNA processing;5.36985511105007e-52!GO:0005840;ribosome;2.35255942199583e-51!GO:0044267;cellular protein metabolic process;3.3811267681112e-51!GO:0044260;cellular macromolecule metabolic process;1.57617228124831e-50!GO:0043283;biopolymer metabolic process;5.06945735255982e-48!GO:0043234;protein complex;6.23859395308988e-48!GO:0033036;macromolecule localization;2.4371625627413e-47!GO:0010467;gene expression;2.68041142012182e-47!GO:0015031;protein transport;3.72715931302848e-47!GO:0031981;nuclear lumen;2.07844336992564e-46!GO:0016043;cellular component organization and biogenesis;5.56604993617857e-45!GO:0003735;structural constituent of ribosome;1.02536488038448e-44!GO:0045184;establishment of protein localization;1.60891879786996e-43!GO:0008104;protein localization;1.70164934880567e-43!GO:0031090;organelle membrane;3.2777791243866e-43!GO:0009059;macromolecule biosynthetic process;1.5649274909273e-39!GO:0033279;ribosomal subunit;1.26134956431892e-38!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;3.32600887727028e-38!GO:0005829;cytosol;1.43200120426361e-37!GO:0046907;intracellular transport;3.46435211006343e-37!GO:0044249;cellular biosynthetic process;4.90455085320165e-37!GO:0016071;mRNA metabolic process;7.47887919730826e-37!GO:0009058;biosynthetic process;2.12515643059389e-36!GO:0043228;non-membrane-bound organelle;4.07261764785594e-36!GO:0043232;intracellular non-membrane-bound organelle;4.07261764785594e-36!GO:0022613;ribonucleoprotein complex biogenesis and assembly;4.81857595770509e-36!GO:0044429;mitochondrial part;6.96040217603721e-36!GO:0008380;RNA splicing;3.03955226232835e-35!GO:0031967;organelle envelope;1.23207722525567e-33!GO:0031975;envelope;2.69406904630445e-33!GO:0006397;mRNA processing;2.74591630512582e-33!GO:0006886;intracellular protein transport;3.63493127636029e-33!GO:0065003;macromolecular complex assembly;1.88305641722248e-32!GO:0022607;cellular component assembly;8.14888506122509e-28!GO:0005830;cytosolic ribosome (sensu Eukaryota);1.0207296498826e-27!GO:0005654;nucleoplasm;1.50171774141469e-26!GO:0006996;organelle organization and biogenesis;2.58553892440323e-26!GO:0005681;spliceosome;4.61434932381047e-25!GO:0051649;establishment of cellular localization;9.67256737358523e-25!GO:0051641;cellular localization;1.50458669377386e-24!GO:0044445;cytosolic part;5.70078150235223e-24!GO:0003676;nucleic acid binding;8.05938562885292e-24!GO:0005730;nucleolus;3.41533670298397e-23!GO:0000166;nucleotide binding;2.74036681426994e-22!GO:0044451;nucleoplasm part;7.81977198508429e-22!GO:0005740;mitochondrial envelope;9.42014136104289e-22!GO:0016070;RNA metabolic process;2.31330140991436e-21!GO:0019866;organelle inner membrane;6.7104563607665e-21!GO:0031966;mitochondrial membrane;1.2018047444175e-20!GO:0015934;large ribosomal subunit;1.71081755586165e-20!GO:0022618;protein-RNA complex assembly;2.63518472124992e-20!GO:0016462;pyrophosphatase activity;2.69471250244795e-20!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;3.01781416455907e-20!GO:0016817;hydrolase activity, acting on acid anhydrides;4.75505184923289e-20!GO:0017111;nucleoside-triphosphatase activity;6.41939298434547e-20!GO:0005743;mitochondrial inner membrane;3.07568053444556e-19!GO:0015935;small ribosomal subunit;3.57349402737421e-19!GO:0012505;endomembrane system;4.73708656192159e-19!GO:0006119;oxidative phosphorylation;6.43616924200173e-19!GO:0016874;ligase activity;6.74450538460557e-19!GO:0006259;DNA metabolic process;7.09370725985845e-19!GO:0006457;protein folding;9.58508736716771e-19!GO:0006512;ubiquitin cycle;2.24005684620623e-18!GO:0008134;transcription factor binding;5.26725108228012e-18!GO:0007049;cell cycle;1.33601220303292e-17!GO:0044455;mitochondrial membrane part;1.37541436041142e-17!GO:0042254;ribosome biogenesis and assembly;1.04661991335963e-16!GO:0031980;mitochondrial lumen;1.10873093980385e-16!GO:0005759;mitochondrial matrix;1.10873093980385e-16!GO:0043412;biopolymer modification;1.52953994567638e-16!GO:0008135;translation factor activity, nucleic acid binding;1.52953994567638e-16!GO:0006605;protein targeting;2.11657812554204e-16!GO:0032553;ribonucleotide binding;2.50937084365635e-15!GO:0032555;purine ribonucleotide binding;2.50937084365635e-15!GO:0051082;unfolded protein binding;3.85742526494699e-15!GO:0017076;purine nucleotide binding;4.0648074812182e-15!GO:0043285;biopolymer catabolic process;5.65999077140488e-15!GO:0005783;endoplasmic reticulum;7.51104682597736e-15!GO:0051603;proteolysis involved in cellular protein catabolic process;7.91227726540024e-15!GO:0019941;modification-dependent protein catabolic process;7.91227726540024e-15!GO:0043632;modification-dependent macromolecule catabolic process;7.91227726540024e-15!GO:0005794;Golgi apparatus;8.86582461351198e-15!GO:0048770;pigment granule;8.86582461351198e-15!GO:0042470;melanosome;8.86582461351198e-15!GO:0000502;proteasome complex (sensu Eukaryota);1.06497006972415e-14!GO:0006464;protein modification process;1.15726591219867e-14!GO:0005761;mitochondrial ribosome;1.15726591219867e-14!GO:0000313;organellar ribosome;1.15726591219867e-14!GO:0006511;ubiquitin-dependent protein catabolic process;1.75061722602015e-14!GO:0044257;cellular protein catabolic process;2.24760229970276e-14!GO:0044265;cellular macromolecule catabolic process;2.78927080202308e-14!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);3.66673677514249e-14!GO:0005746;mitochondrial respiratory chain;5.69687731126215e-14!GO:0048193;Golgi vesicle transport;9.90340971887015e-14!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);1.02377195922605e-13!GO:0000398;nuclear mRNA splicing, via spliceosome;1.14772860001241e-13!GO:0000375;RNA splicing, via transesterification reactions;1.14772860001241e-13!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;1.14772860001241e-13!GO:0043687;post-translational protein modification;1.49422224385535e-13!GO:0022402;cell cycle process;1.94018783954343e-13!GO:0006913;nucleocytoplasmic transport;6.88038247066016e-13!GO:0005524;ATP binding;7.30309750537762e-13!GO:0016192;vesicle-mediated transport;7.30358004479604e-13!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;7.67464865999602e-13!GO:0030163;protein catabolic process;7.67464865999602e-13!GO:0003743;translation initiation factor activity;7.87874407985561e-13!GO:0044432;endoplasmic reticulum part;8.41118255224839e-13!GO:0006413;translational initiation;8.78538772079162e-13!GO:0050136;NADH dehydrogenase (quinone) activity;1.03947397726213e-12!GO:0003954;NADH dehydrogenase activity;1.03947397726213e-12!GO:0008137;NADH dehydrogenase (ubiquinone) activity;1.03947397726213e-12!GO:0009057;macromolecule catabolic process;1.06192617577858e-12!GO:0051169;nuclear transport;1.32647544646579e-12!GO:0012501;programmed cell death;1.45499859997816e-12!GO:0032559;adenyl ribonucleotide binding;1.66922523188899e-12!GO:0006399;tRNA metabolic process;2.1162827461689e-12!GO:0006915;apoptosis;2.22387872420416e-12!GO:0030554;adenyl nucleotide binding;3.58881089232138e-12!GO:0006974;response to DNA damage stimulus;3.73768701357258e-12!GO:0005635;nuclear envelope;3.82164440149282e-12!GO:0006446;regulation of translational initiation;6.74411273672246e-12!GO:0003712;transcription cofactor activity;9.52409106244439e-12!GO:0000278;mitotic cell cycle;1.92266422346297e-11!GO:0006366;transcription from RNA polymerase II promoter;2.95680787544416e-11!GO:0006364;rRNA processing;4.24965500397234e-11!GO:0016072;rRNA metabolic process;4.38055285523379e-11!GO:0031965;nuclear membrane;5.17156284950902e-11!GO:0016604;nuclear body;6.43305179931655e-11!GO:0008219;cell death;6.62386471790548e-11!GO:0016265;death;6.62386471790548e-11!GO:0008639;small protein conjugating enzyme activity;7.39584421186398e-11!GO:0042775;organelle ATP synthesis coupled electron transport;7.67733233365811e-11!GO:0042773;ATP synthesis coupled electron transport;7.67733233365811e-11!GO:0030964;NADH dehydrogenase complex (quinone);7.73581938312459e-11!GO:0045271;respiratory chain complex I;7.73581938312459e-11!GO:0005747;mitochondrial respiratory chain complex I;7.73581938312459e-11!GO:0044453;nuclear membrane part;9.12708418095142e-11!GO:0006461;protein complex assembly;9.30979707731483e-11!GO:0004386;helicase activity;1.54381577771363e-10!GO:0004842;ubiquitin-protein ligase activity;1.61761123655706e-10!GO:0019787;small conjugating protein ligase activity;2.17480436566067e-10!GO:0016887;ATPase activity;2.20352096247802e-10!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;2.56520813728721e-10!GO:0017038;protein import;2.91677838394432e-10!GO:0044248;cellular catabolic process;4.11019923441301e-10!GO:0051726;regulation of cell cycle;4.16919987490956e-10!GO:0000074;regulation of progression through cell cycle;4.71068537589047e-10!GO:0042175;nuclear envelope-endoplasmic reticulum network;5.16575582763713e-10!GO:0006281;DNA repair;5.28604302084074e-10!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;8.50239911866654e-10!GO:0016879;ligase activity, forming carbon-nitrogen bonds;9.4251484910802e-10!GO:0008026;ATP-dependent helicase activity;1.10703639909326e-09!GO:0005789;endoplasmic reticulum membrane;1.47591370503651e-09!GO:0050794;regulation of cellular process;1.54166469227336e-09!GO:0005643;nuclear pore;1.69815466848259e-09!GO:0042623;ATPase activity, coupled;2.06977728943912e-09!GO:0051186;cofactor metabolic process;2.41861435041383e-09!GO:0005768;endosome;3.03730257819637e-09!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;3.26809305037317e-09!GO:0004812;aminoacyl-tRNA ligase activity;3.26809305037317e-09!GO:0016875;ligase activity, forming carbon-oxygen bonds;3.26809305037317e-09!GO:0008565;protein transporter activity;4.03227339946617e-09!GO:0016881;acid-amino acid ligase activity;4.31786869539916e-09!GO:0043038;amino acid activation;7.87406525241067e-09!GO:0006418;tRNA aminoacylation for protein translation;7.87406525241067e-09!GO:0043039;tRNA aminoacylation;7.87406525241067e-09!GO:0048523;negative regulation of cellular process;9.07583284694837e-09!GO:0016787;hydrolase activity;1.05533113789872e-08!GO:0009055;electron carrier activity;1.38775065689367e-08!GO:0005793;ER-Golgi intermediate compartment;1.66823880966507e-08!GO:0006403;RNA localization;1.76144480346954e-08!GO:0005694;chromosome;1.76144480346954e-08!GO:0016607;nuclear speck;1.87440079534065e-08!GO:0065002;intracellular protein transport across a membrane;1.97601227780462e-08!GO:0051246;regulation of protein metabolic process;2.07536013517175e-08!GO:0000087;M phase of mitotic cell cycle;2.2061736794709e-08!GO:0009719;response to endogenous stimulus;2.46276112596395e-08!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;2.46411499836372e-08!GO:0007249;I-kappaB kinase/NF-kappaB cascade;2.57649861162268e-08!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;2.71533707697369e-08!GO:0050657;nucleic acid transport;3.01095327378659e-08!GO:0051236;establishment of RNA localization;3.01095327378659e-08!GO:0050658;RNA transport;3.01095327378659e-08!GO:0007067;mitosis;3.45353402213062e-08!GO:0046930;pore complex;4.02384242485778e-08!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;4.45778038294421e-08!GO:0042981;regulation of apoptosis;4.61467687550421e-08!GO:0043067;regulation of programmed cell death;4.70136639591112e-08!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;5.4344358526517e-08!GO:0016779;nucleotidyltransferase activity;7.35566545897891e-08!GO:0009259;ribonucleotide metabolic process;8.09663398849711e-08!GO:0048475;coated membrane;8.36406591221962e-08!GO:0030117;membrane coat;8.36406591221962e-08!GO:0051276;chromosome organization and biogenesis;1.08755647064209e-07!GO:0006732;coenzyme metabolic process;1.23291453639347e-07!GO:0006163;purine nucleotide metabolic process;1.27118055341153e-07!GO:0030120;vesicle coat;1.27848177297485e-07!GO:0030662;coated vesicle membrane;1.27848177297485e-07!GO:0007005;mitochondrion organization and biogenesis;1.30671209186874e-07!GO:0032446;protein modification by small protein conjugation;1.44570401773653e-07!GO:0003924;GTPase activity;1.66212311512997e-07!GO:0015986;ATP synthesis coupled proton transport;1.80050993765008e-07!GO:0015985;energy coupled proton transport, down electrochemical gradient;1.80050993765008e-07!GO:0006260;DNA replication;1.93144073937138e-07!GO:0016567;protein ubiquitination;2.13213440764034e-07!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;2.27535496856933e-07!GO:0006164;purine nucleotide biosynthetic process;2.27673266608238e-07!GO:0048519;negative regulation of biological process;2.28550917355324e-07!GO:0009260;ribonucleotide biosynthetic process;2.56195489792479e-07!GO:0009150;purine ribonucleotide metabolic process;3.71839233023383e-07!GO:0051170;nuclear import;4.40676072885872e-07!GO:0006888;ER to Golgi vesicle-mediated transport;5.24509004015826e-07!GO:0022403;cell cycle phase;6.52125986161792e-07!GO:0009152;purine ribonucleotide biosynthetic process;6.71917891803678e-07!GO:0005667;transcription factor complex;7.06127203948815e-07!GO:0016564;transcription repressor activity;7.63142533426908e-07!GO:0030532;small nuclear ribonucleoprotein complex;8.83067704195287e-07!GO:0006793;phosphorus metabolic process;9.10787172425517e-07!GO:0006796;phosphate metabolic process;9.10787172425517e-07!GO:0043623;cellular protein complex assembly;9.37323529218294e-07!GO:0006916;anti-apoptosis;9.37323529218294e-07!GO:0006325;establishment and/or maintenance of chromatin architecture;9.4295600681104e-07!GO:0044427;chromosomal part;9.5445772904803e-07!GO:0043069;negative regulation of programmed cell death;9.88835188643816e-07!GO:0006606;protein import into nucleus;9.92233226718247e-07!GO:0044431;Golgi apparatus part;1.18488981205153e-06!GO:0019829;cation-transporting ATPase activity;1.19332957676543e-06!GO:0000245;spliceosome assembly;1.39610105936512e-06!GO:0051028;mRNA transport;1.40632376919266e-06!GO:0006754;ATP biosynthetic process;1.43445112799792e-06!GO:0006753;nucleoside phosphate metabolic process;1.43445112799792e-06!GO:0031324;negative regulation of cellular metabolic process;1.44905499569649e-06!GO:0051188;cofactor biosynthetic process;1.46955258502372e-06!GO:0009142;nucleoside triphosphate biosynthetic process;1.56048679256508e-06!GO:0009201;ribonucleoside triphosphate biosynthetic process;1.56048679256508e-06!GO:0016563;transcription activator activity;1.84144992584896e-06!GO:0043066;negative regulation of apoptosis;1.92395891926194e-06!GO:0009141;nucleoside triphosphate metabolic process;1.98578376147241e-06!GO:0009199;ribonucleoside triphosphate metabolic process;2.16484408813355e-06!GO:0043566;structure-specific DNA binding;2.60531264870126e-06!GO:0048522;positive regulation of cellular process;2.85209562507503e-06!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;2.85209562507503e-06!GO:0006323;DNA packaging;2.85209562507503e-06!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;2.8893537500666e-06!GO:0009145;purine nucleoside triphosphate biosynthetic process;2.8893537500666e-06!GO:0046034;ATP metabolic process;3.09921348801975e-06!GO:0009056;catabolic process;3.20333564328047e-06!GO:0015630;microtubule cytoskeleton;3.25612256787006e-06!GO:0009205;purine ribonucleoside triphosphate metabolic process;3.8296703775091e-06!GO:0009144;purine nucleoside triphosphate metabolic process;3.8296703775091e-06!GO:0007243;protein kinase cascade;3.83931688897974e-06!GO:0015078;hydrogen ion transmembrane transporter activity;4.18576155651825e-06!GO:0003899;DNA-directed RNA polymerase activity;4.35762515285589e-06!GO:0003724;RNA helicase activity;4.36976489618081e-06!GO:0005813;centrosome;4.52147655486493e-06!GO:0003714;transcription corepressor activity;4.67571645668303e-06!GO:0003697;single-stranded DNA binding;4.74089720248566e-06!GO:0005839;proteasome core complex (sensu Eukaryota);4.75542881075839e-06!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;4.8666385120066e-06!GO:0044440;endosomal part;6.07716975632892e-06!GO:0010008;endosome membrane;6.07716975632892e-06!GO:0006357;regulation of transcription from RNA polymerase II promoter;6.1126173330205e-06!GO:0050789;regulation of biological process;6.85443080186161e-06!GO:0009967;positive regulation of signal transduction;7.57249655478782e-06!GO:0005762;mitochondrial large ribosomal subunit;7.69931511616159e-06!GO:0000315;organellar large ribosomal subunit;7.69931511616159e-06!GO:0045259;proton-transporting ATP synthase complex;8.08592389201658e-06!GO:0065004;protein-DNA complex assembly;8.74977572756544e-06!GO:0016469;proton-transporting two-sector ATPase complex;8.99616948874405e-06!GO:0009108;coenzyme biosynthetic process;9.79059841556458e-06!GO:0003713;transcription coactivator activity;1.12156014120524e-05!GO:0051301;cell division;1.12156014120524e-05!GO:0005770;late endosome;1.69189170433776e-05!GO:0031202;RNA splicing factor activity, transesterification mechanism;1.85384184213154e-05!GO:0000279;M phase;1.8760434413343e-05!GO:0006613;cotranslational protein targeting to membrane;2.19088670771069e-05!GO:0009060;aerobic respiration;2.27782746109209e-05!GO:0019222;regulation of metabolic process;2.43433697126669e-05!GO:0019899;enzyme binding;2.45322735553758e-05!GO:0004298;threonine endopeptidase activity;2.45892272381365e-05!GO:0005815;microtubule organizing center;2.51144220442476e-05!GO:0045786;negative regulation of progression through cell cycle;2.598996883075e-05!GO:0009117;nucleotide metabolic process;2.73654474909596e-05!GO:0016740;transferase activity;2.7694553069099e-05!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;3.22223550808605e-05!GO:0051168;nuclear export;3.634869961622e-05!GO:0016568;chromatin modification;3.9379642715969e-05!GO:0051427;hormone receptor binding;4.2775727561942e-05!GO:0005525;GTP binding;4.2775727561942e-05!GO:0000785;chromatin;4.2775727561942e-05!GO:0016310;phosphorylation;4.36211269716539e-05!GO:0000139;Golgi membrane;4.41860680128915e-05!GO:0009892;negative regulation of metabolic process;5.00861877254958e-05!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;5.03887138391865e-05!GO:0006752;group transfer coenzyme metabolic process;5.19840576964027e-05!GO:0005798;Golgi-associated vesicle;7.5223552967559e-05!GO:0008033;tRNA processing;7.72703592423064e-05!GO:0035257;nuclear hormone receptor binding;8.90282893676914e-05!GO:0016772;transferase activity, transferring phosphorus-containing groups;9.41604676948097e-05!GO:0048471;perinuclear region of cytoplasm;9.44504493685183e-05!GO:0005769;early endosome;0.00010881529682922!GO:0043681;protein import into mitochondrion;0.000113167574846725!GO:0016481;negative regulation of transcription;0.000121433188528608!GO:0031988;membrane-bound vesicle;0.000145850804620932!GO:0015077;monovalent inorganic cation transmembrane transporter activity;0.000152081987438848!GO:0006333;chromatin assembly or disassembly;0.000152081987438848!GO:0008186;RNA-dependent ATPase activity;0.000152752522828042!GO:0045941;positive regulation of transcription;0.000159921222218235!GO:0008654;phospholipid biosynthetic process;0.000164719719243175!GO:0043021;ribonucleoprotein binding;0.000169046751078677!GO:0044452;nucleolar part;0.000169046751078677!GO:0016023;cytoplasmic membrane-bound vesicle;0.000169608067147332!GO:0005788;endoplasmic reticulum lumen;0.000176066380913896!GO:0045333;cellular respiration;0.000183400850824241!GO:0005048;signal sequence binding;0.000192897486906938!GO:0000151;ubiquitin ligase complex;0.000195273575910631!GO:0000314;organellar small ribosomal subunit;0.00020577498741417!GO:0005763;mitochondrial small ribosomal subunit;0.00020577498741417!GO:0045454;cell redox homeostasis;0.000251870624902718!GO:0030867;rough endoplasmic reticulum membrane;0.000260461654283514!GO:0016197;endosome transport;0.000270087407505331!GO:0065009;regulation of a molecular function;0.000287010837055029!GO:0032561;guanyl ribonucleotide binding;0.000352053562409218!GO:0019001;guanyl nucleotide binding;0.000352053562409218!GO:0042802;identical protein binding;0.000361010327798802!GO:0045893;positive regulation of transcription, DNA-dependent;0.000370211568608768!GO:0031982;vesicle;0.000381103065469162!GO:0031252;leading edge;0.000395668117802818!GO:0030880;RNA polymerase complex;0.000402604290762379!GO:0006099;tricarboxylic acid cycle;0.000422850081718895!GO:0046356;acetyl-CoA catabolic process;0.000422850081718895!GO:0004004;ATP-dependent RNA helicase activity;0.000424322577600234!GO:0033116;ER-Golgi intermediate compartment membrane;0.000433157710317141!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.000443434370897849!GO:0005819;spindle;0.000455444015564506!GO:0048518;positive regulation of biological process;0.000476486327636571!GO:0003729;mRNA binding;0.000501369922122162!GO:0006261;DNA-dependent DNA replication;0.000547860841510066!GO:0000079;regulation of cyclin-dependent protein kinase activity;0.000574813460194101!GO:0005852;eukaryotic translation initiation factor 3 complex;0.000604921711136329!GO:0031410;cytoplasmic vesicle;0.000679327323526438!GO:0006084;acetyl-CoA metabolic process;0.000679327323526438!GO:0006626;protein targeting to mitochondrion;0.00071845775251276!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;0.000828696815434774!GO:0008250;oligosaccharyl transferase complex;0.000854153599000518!GO:0006414;translational elongation;0.000866363083767813!GO:0055029;nuclear DNA-directed RNA polymerase complex;0.000899664662894045!GO:0000428;DNA-directed RNA polymerase complex;0.000899664662894045!GO:0006417;regulation of translation;0.000911828619591586!GO:0006352;transcription initiation;0.000912591343773423!GO:0016281;eukaryotic translation initiation factor 4F complex;0.000993698532999144!GO:0031323;regulation of cellular metabolic process;0.00102782679745766!GO:0051789;response to protein stimulus;0.00105949150224935!GO:0006986;response to unfolded protein;0.00105949150224935!GO:0004576;oligosaccharyl transferase activity;0.00106213216552863!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.00107075368096979!GO:0005905;coated pit;0.00110140064771006!GO:0030118;clathrin coat;0.00122970785909928!GO:0051329;interphase of mitotic cell cycle;0.00124607853271161!GO:0031072;heat shock protein binding;0.00124754603534817!GO:0046489;phosphoinositide biosynthetic process;0.00125277686555246!GO:0009109;coenzyme catabolic process;0.00128293374447441!GO:0007006;mitochondrial membrane organization and biogenesis;0.00132472890033517!GO:0006612;protein targeting to membrane;0.00135532923651977!GO:0016272;prefoldin complex;0.00135622142171748!GO:0003684;damaged DNA binding;0.00136564741298255!GO:0006402;mRNA catabolic process;0.00136777549783824!GO:0003690;double-stranded DNA binding;0.00141407382057404!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.0014228563413522!GO:0005885;Arp2/3 protein complex;0.0014228563413522!GO:0005773;vacuole;0.00160352558553549!GO:0006839;mitochondrial transport;0.00162485846205326!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00168372167115579!GO:0046474;glycerophospholipid biosynthetic process;0.0017757188869165!GO:0065007;biological regulation;0.00188333355504032!GO:0051920;peroxiredoxin activity;0.00192125913792153!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00199780425762531!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00199780425762531!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00199780425762531!GO:0006891;intra-Golgi vesicle-mediated transport;0.00207677311714915!GO:0045892;negative regulation of transcription, DNA-dependent;0.00214989767496256!GO:0030119;AP-type membrane coat adaptor complex;0.00215807346249377!GO:0006350;transcription;0.00216098573703064!GO:0051187;cofactor catabolic process;0.00216756395376375!GO:0007264;small GTPase mediated signal transduction;0.00222832105728522!GO:0006401;RNA catabolic process;0.00224536251652277!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00229323129632716!GO:0051252;regulation of RNA metabolic process;0.00230906568744158!GO:0030658;transport vesicle membrane;0.00235443732273587!GO:0018196;peptidyl-asparagine modification;0.00248244703725997!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.00248244703725997!GO:0030663;COPI coated vesicle membrane;0.00248268825167844!GO:0030126;COPI vesicle coat;0.00248268825167844!GO:0006405;RNA export from nucleus;0.00262531409960495!GO:0008139;nuclear localization sequence binding;0.00270325676444593!GO:0016363;nuclear matrix;0.00272306769424664!GO:0007088;regulation of mitosis;0.00273080822654331!GO:0003711;transcription elongation regulator activity;0.00275961814294118!GO:0048500;signal recognition particle;0.00296551512250962!GO:0030131;clathrin adaptor complex;0.00341712823688054!GO:0005684;U2-dependent spliceosome;0.00347629683589483!GO:0016044;membrane organization and biogenesis;0.00347629683589483!GO:0030137;COPI-coated vesicle;0.00347629683589483!GO:0051325;interphase;0.00353462129000286!GO:0019843;rRNA binding;0.00369892207407434!GO:0016311;dephosphorylation;0.00370280847521257!GO:0000049;tRNA binding;0.00371445584289877!GO:0006091;generation of precursor metabolites and energy;0.00380652169247817!GO:0030036;actin cytoskeleton organization and biogenesis;0.00382238292388342!GO:0008312;7S RNA binding;0.00383829746447684!GO:0004674;protein serine/threonine kinase activity;0.00386165508043774!GO:0033673;negative regulation of kinase activity;0.00390582427714102!GO:0006469;negative regulation of protein kinase activity;0.00390582427714102!GO:0001726;ruffle;0.00405793873763882!GO:0030176;integral to endoplasmic reticulum membrane;0.00422121743745246!GO:0006611;protein export from nucleus;0.00458091482371707!GO:0030132;clathrin coat of coated pit;0.00459282611335294!GO:0008243;plasminogen activator activity;0.00462629773421578!GO:0016859;cis-trans isomerase activity;0.00464068830969935!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;0.00466098818946287!GO:0045045;secretory pathway;0.00466098818946287!GO:0000323;lytic vacuole;0.00480790991926192!GO:0005764;lysosome;0.00480790991926192!GO:0008632;apoptotic program;0.00481774877613137!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.00481774877613137!GO:0004527;exonuclease activity;0.00482522605980494!GO:0008047;enzyme activator activity;0.00488646154796094!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.0049081455307558!GO:0015399;primary active transmembrane transporter activity;0.0049081455307558!GO:0050790;regulation of catalytic activity;0.00499397412921929!GO:0016853;isomerase activity;0.00519224751947187!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.00529609911352244!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.00529609911352244!GO:0005669;transcription factor TFIID complex;0.00532526539793798!GO:0000075;cell cycle checkpoint;0.00544757767130676!GO:0031326;regulation of cellular biosynthetic process;0.00573560653125916!GO:0006383;transcription from RNA polymerase III promoter;0.00573560653125916!GO:0006368;RNA elongation from RNA polymerase II promoter;0.00573560653125916!GO:0009889;regulation of biosynthetic process;0.00603628276650853!GO:0046822;regulation of nucleocytoplasmic transport;0.00611294504627189!GO:0005665;DNA-directed RNA polymerase II, core complex;0.00619852154468858!GO:0030660;Golgi-associated vesicle membrane;0.00628758558231055!GO:0007051;spindle organization and biogenesis;0.00632630499980714!GO:0051338;regulation of transferase activity;0.00640161297044!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.00654443337928544!GO:0045047;protein targeting to ER;0.00654443337928544!GO:0051348;negative regulation of transferase activity;0.0066227671082548!GO:0007050;cell cycle arrest;0.00669730294018809!GO:0043022;ribosome binding;0.00706547711263491!GO:0031497;chromatin assembly;0.00706547711263491!GO:0035258;steroid hormone receptor binding;0.00708751228977482!GO:0006334;nucleosome assembly;0.00711385569770917!GO:0010468;regulation of gene expression;0.00720786206145064!GO:0004518;nuclease activity;0.00722906755355978!GO:0000059;protein import into nucleus, docking;0.00748672309411772!GO:0006509;membrane protein ectodomain proteolysis;0.00804494853575887!GO:0033619;membrane protein proteolysis;0.00804494853575887!GO:0004860;protein kinase inhibitor activity;0.00808264994082812!GO:0003746;translation elongation factor activity;0.00834111257486803!GO:0030659;cytoplasmic vesicle membrane;0.00859935583108478!GO:0009165;nucleotide biosynthetic process;0.00873949146457138!GO:0006302;double-strand break repair;0.00908848926400235!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.00937228594311335!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.00937598148337008!GO:0000307;cyclin-dependent protein kinase holoenzyme complex;0.00976988882392711!GO:0006354;RNA elongation;0.00996756020507537!GO:0030125;clathrin vesicle coat;0.0103030401659376!GO:0030665;clathrin coated vesicle membrane;0.0103030401659376!GO:0009893;positive regulation of metabolic process;0.0103365903729551!GO:0004721;phosphoprotein phosphatase activity;0.0103397110732421!GO:0016791;phosphoric monoester hydrolase activity;0.0103618151236278!GO:0005791;rough endoplasmic reticulum;0.0104586779539524!GO:0000082;G1/S transition of mitotic cell cycle;0.0105222558606071!GO:0030127;COPII vesicle coat;0.0107209326984036!GO:0012507;ER to Golgi transport vesicle membrane;0.0107209326984036!GO:0004532;exoribonuclease activity;0.0107398868674545!GO:0016896;exoribonuclease activity, producing 5'-phosphomonoesters;0.0107398868674545!GO:0043488;regulation of mRNA stability;0.0108118421217662!GO:0043487;regulation of RNA stability;0.0108118421217662!GO:0043549;regulation of kinase activity;0.0108316735779947!GO:0008637;apoptotic mitochondrial changes;0.010939569754196!GO:0006289;nucleotide-excision repair;0.0112031102151614!GO:0030134;ER to Golgi transport vesicle;0.0113824264015651!GO:0051052;regulation of DNA metabolic process;0.0113938145748275!GO:0006458;'de novo' protein folding;0.0114173350721502!GO:0051084;'de novo' posttranslational protein folding;0.0114173350721502!GO:0048144;fibroblast proliferation;0.0114239784410853!GO:0048145;regulation of fibroblast proliferation;0.0114239784410853!GO:0032200;telomere organization and biogenesis;0.0115376463903531!GO:0000723;telomere maintenance;0.0115376463903531!GO:0030133;transport vesicle;0.0118482106539288!GO:0007242;intracellular signaling cascade;0.0119364637312844!GO:0009112;nucleobase metabolic process;0.0121398683778323!GO:0006520;amino acid metabolic process;0.0122422892545177!GO:0006595;polyamine metabolic process;0.0123638462559322!GO:0046966;thyroid hormone receptor binding;0.0125153646594919!GO:0001836;release of cytochrome c from mitochondria;0.0128002226985072!GO:0005874;microtubule;0.0131199327660977!GO:0006984;ER-nuclear signaling pathway;0.0132490826965844!GO:0016251;general RNA polymerase II transcription factor activity;0.0132490826965844!GO:0007007;inner mitochondrial membrane organization and biogenesis;0.0132569546209017!GO:0051059;NF-kappaB binding;0.0133276306261169!GO:0006892;post-Golgi vesicle-mediated transport;0.0136625167470054!GO:0045936;negative regulation of phosphate metabolic process;0.0139140652848795!GO:0005149;interleukin-1 receptor binding;0.0139140652848795!GO:0031529;ruffle organization and biogenesis;0.0142021960497451!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0142483001495091!GO:0015002;heme-copper terminal oxidase activity;0.0142483001495091!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0142483001495091!GO:0004129;cytochrome-c oxidase activity;0.0142483001495091!GO:0005637;nuclear inner membrane;0.0142647850745905!GO:0051087;chaperone binding;0.0143072627520468!GO:0009966;regulation of signal transduction;0.0143441950127571!GO:0051540;metal cluster binding;0.0143441950127571!GO:0051536;iron-sulfur cluster binding;0.0143441950127571!GO:0030029;actin filament-based process;0.0143501580733269!GO:0043189;H4/H2A histone acetyltransferase complex;0.0144126911829355!GO:0006506;GPI anchor biosynthetic process;0.0145594151428801!GO:0044433;cytoplasmic vesicle part;0.0145942835127472!GO:0048146;positive regulation of fibroblast proliferation;0.0146353533528599!GO:0007010;cytoskeleton organization and biogenesis;0.0146353533528599!GO:0048468;cell development;0.0149563603543884!GO:0005832;chaperonin-containing T-complex;0.0149565475066199!GO:0045859;regulation of protein kinase activity;0.0155213121914551!GO:0031902;late endosome membrane;0.0155213121914551!GO:0008287;protein serine/threonine phosphatase complex;0.0156821745308321!GO:0046426;negative regulation of JAK-STAT cascade;0.0157303927333377!GO:0048487;beta-tubulin binding;0.0158843327571498!GO:0008538;proteasome activator activity;0.0163836146347!GO:0006497;protein amino acid lipidation;0.0165400611488949!GO:0043624;cellular protein complex disassembly;0.01655860004621!GO:0006376;mRNA splice site selection;0.0168623270532408!GO:0000389;nuclear mRNA 3'-splice site recognition;0.0168623270532408!GO:0031968;organelle outer membrane;0.0171188939609297!GO:0031124;mRNA 3'-end processing;0.0171290375707881!GO:0032508;DNA duplex unwinding;0.0171696480075026!GO:0032392;DNA geometric change;0.0171696480075026!GO:0003682;chromatin binding;0.0171696480075026!GO:0000178;exosome (RNase complex);0.0171696480075026!GO:0022890;inorganic cation transmembrane transporter activity;0.0171696480075026!GO:0008234;cysteine-type peptidase activity;0.0171696480075026!GO:0043492;ATPase activity, coupled to movement of substances;0.0175124435015771!GO:0019867;outer membrane;0.0175152987236487!GO:0006650;glycerophospholipid metabolic process;0.0175197006446632!GO:0030032;lamellipodium biogenesis;0.0178603224296163!GO:0043065;positive regulation of apoptosis;0.0185467910947791!GO:0030384;phosphoinositide metabolic process;0.0193298506340826!GO:0031325;positive regulation of cellular metabolic process;0.0194983998044062!GO:0043161;proteasomal ubiquitin-dependent protein catabolic process;0.0194983998044062!GO:0031901;early endosome membrane;0.0194997902236272!GO:0022406;membrane docking;0.0195617591334953!GO:0048278;vesicle docking;0.0195617591334953!GO:0016584;nucleosome positioning;0.0195666061974604!GO:0035267;NuA4 histone acetyltransferase complex;0.019638355853359!GO:0019219;regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0199637976372245!GO:0006818;hydrogen transport;0.0199666935861072!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.0200747719184793!GO:0006505;GPI anchor metabolic process;0.0202151797003238!GO:0030521;androgen receptor signaling pathway;0.0202151797003238!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.0202383646274797!GO:0017166;vinculin binding;0.0205201458381658!GO:0012506;vesicle membrane;0.0206943301305816!GO:0006470;protein amino acid dephosphorylation;0.0208800962833337!GO:0046983;protein dimerization activity;0.0211680998444935!GO:0043068;positive regulation of programmed cell death;0.0214742304862956!GO:0016491;oxidoreductase activity;0.0221086268397519!GO:0007093;mitotic cell cycle checkpoint;0.0226175613919532!GO:0008361;regulation of cell size;0.0228036088361897!GO:0045603;positive regulation of endothelial cell differentiation;0.0231807888529419!GO:0000123;histone acetyltransferase complex;0.0231952613073023!GO:0015631;tubulin binding;0.0234186060868534!GO:0004680;casein kinase activity;0.0239664028010845!GO:0000096;sulfur amino acid metabolic process;0.0241490009465959!GO:0042326;negative regulation of phosphorylation;0.0252366430620224!GO:0060166;olfactory pit development;0.0252933681196205!GO:0021768;nucleus accumbens development;0.0252933681196205!GO:0002072;optic cup morphogenesis involved in camera-type eye development;0.0252933681196205!GO:0005100;Rho GTPase activator activity;0.0255159757761393!GO:0015980;energy derivation by oxidation of organic compounds;0.0261372076942046!GO:0005741;mitochondrial outer membrane;0.0262471772350569!GO:0006275;regulation of DNA replication;0.0262751991486073!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.0262897259562854!GO:0015992;proton transport;0.0262897259562854!GO:0030031;cell projection biogenesis;0.0269410971719953!GO:0046483;heterocycle metabolic process;0.0269951981591667!GO:0046467;membrane lipid biosynthetic process;0.0271140830761579!GO:0051085;chaperone cofactor-dependent protein folding;0.0273323588365202!GO:0045947;negative regulation of translational initiation;0.0274143130106066!GO:0008601;protein phosphatase type 2A regulator activity;0.0274680915760686!GO:0016485;protein processing;0.0278231521915705!GO:0009116;nucleoside metabolic process;0.02873705084651!GO:0005096;GTPase activator activity;0.0287651453550633!GO:0005657;replication fork;0.029384865160275!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.0294550148169079!GO:0000781;chromosome, telomeric region;0.0295402301431843!GO:0005869;dynactin complex;0.0296815474914152!GO:0007041;lysosomal transport;0.0298178998377341!GO:0051101;regulation of DNA binding;0.0299976414718958!GO:0022415;viral reproductive process;0.0300570297158418!GO:0006950;response to stress;0.0303732721992976!GO:0032984;macromolecular complex disassembly;0.0305185627920113!GO:0045792;negative regulation of cell size;0.0308764671695662!GO:0006904;vesicle docking during exocytosis;0.0308956531671064!GO:0006144;purine base metabolic process;0.0309785849976241!GO:0005856;cytoskeleton;0.0310128083247414!GO:0042719;mitochondrial intermembrane space protein transporter complex;0.0314085520580367!GO:0045039;protein import into mitochondrial inner membrane;0.0314085520580367!GO:0019210;kinase inhibitor activity;0.0314534638221464!GO:0050681;androgen receptor binding;0.0321101850725224!GO:0032774;RNA biosynthetic process;0.0326155673567975!GO:0003702;RNA polymerase II transcription factor activity;0.0326155673567975!GO:0008333;endosome to lysosome transport;0.0327077351765448!GO:0000209;protein polyubiquitination;0.0327901576011721!GO:0006607;NLS-bearing substrate import into nucleus;0.0328611753681028!GO:0047485;protein N-terminus binding;0.033342189875352!GO:0019904;protein domain specific binding;0.0335940123291167!GO:0003678;DNA helicase activity;0.0336927484736942!GO:0018193;peptidyl-amino acid modification;0.0339864675047659!GO:0000339;RNA cap binding;0.0339864675047659!GO:0030308;negative regulation of cell growth;0.0341532536732943!GO:0009303;rRNA transcription;0.0351577279343098!GO:0030833;regulation of actin filament polymerization;0.0352429014027928!GO:0007034;vacuolar transport;0.0356083489102792!GO:0051539;4 iron, 4 sulfur cluster binding;0.0362110287858953!GO:0000159;protein phosphatase type 2A complex;0.0362764357644286!GO:0006351;transcription, DNA-dependent;0.0362764357644286!GO:0043433;negative regulation of transcription factor activity;0.0362764357644286!GO:0031371;ubiquitin conjugating enzyme complex;0.0364392598946806!GO:0043284;biopolymer biosynthetic process;0.0364697421788879!GO:0032981;mitochondrial respiratory chain complex I assembly;0.0365103349019226!GO:0010257;NADH dehydrogenase complex assembly;0.0365103349019226!GO:0033108;mitochondrial respiratory chain complex assembly;0.0365103349019226!GO:0009451;RNA modification;0.0365940278194084!GO:0042532;negative regulation of tyrosine phosphorylation of STAT protein;0.0369355602358946!GO:0042518;negative regulation of tyrosine phosphorylation of Stat3 protein;0.0369355602358946!GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;0.0369355602358946!GO:0006378;mRNA polyadenylation;0.0372573625811569!GO:0008180;signalosome;0.0377221005259667!GO:0004722;protein serine/threonine phosphatase activity;0.0377826011958315!GO:0016741;transferase activity, transferring one-carbon groups;0.0385943968215677!GO:0016049;cell growth;0.0387109621813989!GO:0001558;regulation of cell growth;0.0387109621813989!GO:0030911;TPR domain binding;0.0388925686680816!GO:0008408;3'-5' exonuclease activity;0.0390392321646244!GO:0008168;methyltransferase activity;0.0390392321646244!GO:0043241;protein complex disassembly;0.0392051510284756!GO:0007004;telomere maintenance via telomerase;0.0392051510284756!GO:0032507;maintenance of cellular protein localization;0.0392051510284756!GO:0042158;lipoprotein biosynthetic process;0.0392360330250734!GO:0005784;translocon complex;0.0392915904621002!GO:0006268;DNA unwinding during replication;0.0400055900450878!GO:0045926;negative regulation of growth;0.0405311551247271!GO:0000775;chromosome, pericentric region;0.0409502446862744!GO:0017134;fibroblast growth factor binding;0.0409855323777433!GO:0007033;vacuole organization and biogenesis;0.0428566251585383!GO:0000118;histone deacetylase complex;0.0430111055808017!GO:0035035;histone acetyltransferase binding;0.0432401846733256!GO:0007030;Golgi organization and biogenesis;0.0435219051314232!GO:0032940;secretion by cell;0.0436977544215885!GO:0007040;lysosome organization and biogenesis;0.0442760315793976!GO:0007265;Ras protein signal transduction;0.0443167062194943!GO:0031123;RNA 3'-end processing;0.0443391435253272!GO:0042769;DNA damage response, detection of DNA damage;0.0453546061860355!GO:0016796;exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters;0.0453546061860355!GO:0040029;regulation of gene expression, epigenetic;0.0453546061860355!GO:0031575;G1/S transition checkpoint;0.0455782437201215!GO:0004177;aminopeptidase activity;0.0456511649394551!GO:0008097;5S rRNA binding;0.0457137863652319!GO:0008426;protein kinase C inhibitor activity;0.0460073815672338!GO:0006360;transcription from RNA polymerase I promoter;0.0461745542225594!GO:0046588;negative regulation of calcium-dependent cell-cell adhesion;0.0465160133411465!GO:0046586;regulation of calcium-dependent cell-cell adhesion;0.0465160133411465!GO:0008022;protein C-terminus binding;0.0478823703491845!GO:0043154;negative regulation of caspase activity;0.0479316270497255!GO:0006740;NADPH regeneration;0.0481104164515759!GO:0006098;pentose-phosphate shunt;0.0481104164515759!GO:0004850;uridine phosphorylase activity;0.0481444807991347!GO:0005083;small GTPase regulator activity;0.0481444807991347!GO:0008537;proteasome activator complex;0.0481763336724034!GO:0051098;regulation of binding;0.048184149677212!GO:0000175;3'-5'-exoribonuclease activity;0.0494942761283904!GO:0008092;cytoskeletal protein binding;0.0496161052517519!GO:0000776;kinetochore;0.0497714419494981 | |||
|sample_id=10616 | |sample_id=10616 | ||
|sample_note= | |sample_note= |
Revision as of 21:24, 25 June 2012
Name: | squamous cell carcinoma cell line:T3M-5 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11739
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11739
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.287 |
10 | 10 | 0.326 |
100 | 100 | 0.925 |
101 | 101 | 0.27 |
102 | 102 | 0.492 |
103 | 103 | 0.166 |
104 | 104 | 0.558 |
105 | 105 | 0.826 |
106 | 106 | 0.0178 |
107 | 107 | 0.00122 |
108 | 108 | 0.247 |
109 | 109 | 0.0085 |
11 | 11 | 0.599 |
110 | 110 | 0.116 |
111 | 111 | 0.481 |
112 | 112 | 0.563 |
113 | 113 | 0.0833 |
114 | 114 | 0.456 |
115 | 115 | 0.905 |
116 | 116 | 0.246 |
117 | 117 | 0.056 |
118 | 118 | 0.957 |
119 | 119 | 0.538 |
12 | 12 | 0.742 |
120 | 120 | 0.281 |
121 | 121 | 0.581 |
122 | 122 | 0.61 |
123 | 123 | 0.839 |
124 | 124 | 0.089 |
125 | 125 | 0.827 |
126 | 126 | 0.233 |
127 | 127 | 0.658 |
128 | 128 | 0.418 |
129 | 129 | 0.0628 |
13 | 13 | 0.0554 |
130 | 130 | 0.956 |
131 | 131 | 0.831 |
132 | 132 | 0.782 |
133 | 133 | 0.758 |
134 | 134 | 0.0437 |
135 | 135 | 0.0323 |
136 | 136 | 0.0316 |
137 | 137 | 0.455 |
138 | 138 | 0.117 |
139 | 139 | 0.448 |
14 | 14 | 0.999 |
140 | 140 | 0.227 |
141 | 141 | 0.774 |
142 | 142 | 0.628 |
143 | 143 | 0.764 |
144 | 144 | 0.543 |
145 | 145 | 0.271 |
146 | 146 | 0.795 |
147 | 147 | 0.558 |
148 | 148 | 0.714 |
149 | 149 | 0.961 |
15 | 15 | 0.435 |
150 | 150 | 0.588 |
151 | 151 | 0.301 |
152 | 152 | 0.128 |
153 | 153 | 0.898 |
154 | 154 | 0.642 |
155 | 155 | 0.767 |
156 | 156 | 0.433 |
157 | 157 | 0.856 |
158 | 158 | 0.685 |
159 | 159 | 0.482 |
16 | 16 | 0.0296 |
160 | 160 | 0.696 |
161 | 161 | 0.308 |
162 | 162 | 0.455 |
163 | 163 | 0.538 |
164 | 164 | 0.604 |
165 | 165 | 0.284 |
166 | 166 | 0.142 |
167 | 167 | 0.36 |
168 | 168 | 0.801 |
169 | 169 | 0.0475 |
17 | 17 | 0.119 |
18 | 18 | 0.157 |
19 | 19 | 0.982 |
2 | 2 | 0.851 |
20 | 20 | 0.257 |
21 | 21 | 0.903 |
22 | 22 | 0.815 |
23 | 23 | 0.502 |
24 | 24 | 0.197 |
25 | 25 | 0.786 |
26 | 26 | 0.206 |
27 | 27 | 0.71 |
28 | 28 | 0.0801 |
29 | 29 | 0.421 |
3 | 3 | 0.179 |
30 | 30 | 0.392 |
31 | 31 | 0.854 |
32 | 32 | 0.224 |
33 | 33 | 0.0212 |
34 | 34 | 0.128 |
35 | 35 | 0.397 |
36 | 36 | 0.0362 |
37 | 37 | 0.224 |
38 | 38 | 0.181 |
39 | 39 | 0.698 |
4 | 4 | 0.538 |
40 | 40 | 0.196 |
41 | 41 | 0.153 |
42 | 42 | 0.154 |
43 | 43 | 0.694 |
44 | 44 | 0.896 |
45 | 45 | 0.378 |
46 | 46 | 0.0907 |
47 | 47 | 0.265 |
48 | 48 | 0.24 |
49 | 49 | 0.71 |
5 | 5 | 0.349 |
50 | 50 | 0.416 |
51 | 51 | 0.905 |
52 | 52 | 0.874 |
53 | 53 | 0.452 |
54 | 54 | 0.445 |
55 | 55 | 0.0245 |
56 | 56 | 0.444 |
57 | 57 | 0.0319 |
58 | 58 | 0.886 |
59 | 59 | 0.848 |
6 | 6 | 0.95 |
60 | 60 | 0.257 |
61 | 61 | 0.607 |
62 | 62 | 0.815 |
63 | 63 | 0.126 |
64 | 64 | 0.948 |
65 | 65 | 0.358 |
66 | 66 | 0.00476 |
67 | 67 | 0.396 |
68 | 68 | 0.124 |
69 | 69 | 0.951 |
7 | 7 | 0.933 |
70 | 70 | 0.019 |
71 | 71 | 0.136 |
72 | 72 | 0.736 |
73 | 73 | 0.0294 |
74 | 74 | 0.817 |
75 | 75 | 0.0322 |
76 | 76 | 0.278 |
77 | 77 | 0.592 |
78 | 78 | 0.0283 |
79 | 79 | 0.107 |
8 | 8 | 0.279 |
80 | 80 | 0.611 |
81 | 81 | 0.7 |
82 | 82 | 0.647 |
83 | 83 | 0.485 |
84 | 84 | 0.604 |
85 | 85 | 0.969 |
86 | 86 | 0.277 |
87 | 87 | 0.00335 |
88 | 88 | 0.915 |
89 | 89 | 0.332 |
9 | 9 | 0.366 |
90 | 90 | 0.253 |
91 | 91 | 0.234 |
92 | 92 | 0.49 |
93 | 93 | 0.403 |
94 | 94 | 0.765 |
95 | 95 | 0.251 |
96 | 96 | 0.293 |
97 | 97 | 0.221 |
98 | 98 | 0.967 |
99 | 99 | 0.652 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs11739
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000003 cell line sample
FF:0000210 human sample
FF:0102024 squamous cell carcinoma cell line sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000548 (animal cell)
0000066 (epithelial cell)
0000076 (squamous epithelial cell)
0000255 (eukaryotic cell)
DOID: Disease
4 (disease)
162 (cancer)
14566 (disease of cellular proliferation)
0050687 (cell type cancer)
305 (carcinoma)
1749 (squamous cell carcinoma)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA